10.70
price down icon2.82%   -0.31
after-market アフターアワーズ: 10.85 0.15 +1.40%
loading
前日終値:
$11.01
開ける:
$11.17
24時間の取引高:
2.25M
Relative Volume:
1.06
時価総額:
$1.18B
収益:
$139.71M
当期純損益:
$-209.36M
株価収益率:
-3.6149
EPS:
-2.96
ネットキャッシュフロー:
$-160.60M
1週間 パフォーマンス:
-22.07%
1か月 パフォーマンス:
-7.12%
6か月 パフォーマンス:
-50.94%
1年 パフォーマンス:
-51.30%
1日の値動き範囲:
Value
$10.69
$11.48
1週間の範囲:
Value
$9.665
$14.12
52週間の値動き範囲:
Value
$9.66
$25.07

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
名前
Syndax Pharmaceuticals Inc
Name
セクター
Healthcare (1153)
Name
電話
781-419-1400
Name
住所
730 THIRD AVENUE, NEW YORK, MA
Name
職員
184
Name
Twitter
@syndax
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
SNDX's Discussions on Twitter

SNDX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SNDX
Syndax Pharmaceuticals Inc
10.70 1.18B 139.71M -209.36M -160.60M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.99 128.84B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.78 65.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
549.65 39.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.15 33.82B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
231.99 27.60B 3.81B -644.79M -669.77M -6.24

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-24 開始されました UBS Buy
2024-06-28 開始されました Jefferies Buy
2024-01-31 ダウングレード Scotiabank Sector Outperform → Sector Perform
2023-12-22 開始されました Mizuho Buy
2023-10-25 開始されました BofA Securities Buy
2023-10-11 開始されました Goldman Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-11 開始されました Guggenheim Buy
2023-04-17 再開されました BTIG Research Buy
2023-01-31 開始されました Stifel Buy
2023-01-03 開始されました JP Morgan Overweight
2022-07-28 再開されました B. Riley Securities Buy
2022-04-11 開始されました H.C. Wainwright Buy
2022-02-15 開始されました Goldman Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-25 開始されました Citigroup Buy
2021-02-18 開始されました B. Riley Securities Buy
2020-12-03 開始されました Stifel Buy
2020-05-22 アップグレード Citigroup Neutral → Buy
2020-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-18 ダウングレード Citigroup Buy → Neutral
2020-05-11 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-13 繰り返されました H.C. Wainwright Buy
2019-03-08 繰り返されました H.C. Wainwright Buy
2019-01-04 開始されました Robert W. Baird Outperform
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-03-16 開始されました FBR & Co. Outperform
2017-03-02 開始されました Instinet Buy
2016-10-07 開始されました Guggenheim Buy
2016-03-28 開始されました Citigroup Buy
2016-03-28 開始されました JMP Securities Mkt Outperform
2016-03-28 開始されました Morgan Stanley Overweight
すべてを表示

Syndax Pharmaceuticals Inc (SNDX) 最新ニュース

pulisher
07:50 AM

What is B. Riley's Forecast for SNDX Q2 Earnings? - MarketBeat

07:50 AM
pulisher
06:15 AM

Bayesian Capital Management LP Makes New Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

06:15 AM
pulisher
03:17 AM

Marshall Wace LLP Sells 977,280 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

03:17 AM
pulisher
01:29 AM

Algert Global LLC Buys 310,634 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

01:29 AM
pulisher
May 09, 2025

Wall Street Analysts See a 219.98% Upside in Syndax (SNDX): Can the Stock Really Move This High? - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Avidity Partners Management LP Cuts Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

May 09, 2025
pulisher
May 08, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Raised to $17.00 - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Given "Buy" Rating at Guggenheim - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Releases Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Crestline Management LP Grows Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Syndax Announces Participation in May Investor Conferences - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Analysts Are Upgrading Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) After Its Latest Results - simplywall.st

May 08, 2025
pulisher
May 07, 2025

SNDX: Syndax Reveals Significant Phase 2 Trial Results for Revumenib | SNDX Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $36.20 Average Target Price from Analysts - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Syndax Announces Publication of Pivotal Revumenib Data in - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Syndax signals $4B total market opportunity with Revuforj expansion into frontline settings - MSN

May 07, 2025
pulisher
May 07, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 06, 2025

Syndax Pharmaceuticals’ Optimistic Q1 2025 Earnings Call - TipRanks

May 06, 2025
pulisher
May 06, 2025

SNDX: Scotiabank Raises Price Target on Syndax Pharmaceuticals | SNDX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Syndax Pharmaceuticals (SNDX) Buy Rating Reiterated by Guggenhei - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Syndax Pharmaceuticals (SNDX) Buy Rating Reiterated by Guggenheim | SNDX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Scotiabank raises Syndax stock target to $17 on strong sales By Investing.com - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Syndax (SNDX) Price Target Increased by BofA Following Promising Updates | SNDX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

BofA raises Syndax stock price target to $26 on strong Q1 update - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Syndax Pharmaceuticals Q1 Loss Widens - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

Syndax Pharmaceuticals Inc (SNDX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo

May 06, 2025
pulisher
May 06, 2025

Syndax Pharmaceuticals Inc (SNDX) Q1 2025 Earnings Call Highligh - GuruFocus

May 06, 2025
pulisher
May 06, 2025

SNDX Reports Strong Revenue and Cash Position, Focuses on Growth - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Syndax Pharmaceuticals Reports Strong Q1 2025 Results - TipRanks

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Syndax Pharmaceuticals beats Q1 2025 EPS estimates - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Decoding Syndax Pharmaceuticals Inc (SNDX): A Strategic SWOT Ins - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Syndax Pharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SNDX) - Seeking Alpha

May 05, 2025
pulisher
May 05, 2025

Syndax: Q1 Earnings Snapshot - MySA

May 05, 2025
pulisher
May 05, 2025

Syndax Pharmaceuticals earnings beat by $0.26, revenue topped estimates - Investing.com Canada

May 05, 2025
pulisher
May 05, 2025

Syndax Pharmaceuticals Q1 2025 Earnings: EPS Loss of $0.98 Beats Estimates, Revenue Surges to $20 Million - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Syndax Q1 2025 slides: Revuforj revenue hits $20M, cash position remains strong - Investing.com India

May 05, 2025
pulisher
May 05, 2025

Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

Syndax Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2025
pulisher
May 05, 2025

Syndax Q1 2025 slides: Revuforj revenue hits $20M, cash position remains strong By Investing.com - Investing.com South Africa

May 05, 2025
pulisher
May 05, 2025

SNDX Reports Impressive Q1 Revenue, Exceeds Market Expectations | SNDX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Earnings Flash (SNDX) Syndax Pharmaceuticals Posts Q1 Revenue $20M, vs. FactSet Est of $15.6M - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Syndax Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 05, 2025
pulisher
May 05, 2025

Syndax Pharmaceuticals (SNDX) Projected to Post Earnings on Tuesday - MarketBeat

May 05, 2025
pulisher
May 04, 2025

Adage Capital Partners GP L.L.C. Sells 195,760 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

(SNDX) Investment Analysis - news.stocktradersdaily.com

May 04, 2025

Syndax Pharmaceuticals Inc (SNDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):